Clinical efficacy of clozapine in treatment-refractory schizophrenic patients

By Min-Soo L.   In-Kwa J.   Dong-Il K.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 342-342

Elsevier

Access to resources Recommend Favorite

Steady-state Pharmacokinetics of Clozapine in Refractory Schizophrenic Saudi Arabian Patients

By Hussein R.   Gad A.   Raines D.A.   Chaleby K.   Al-Rawithi S.   El-Yazigi A.  

Pharmacy and Pharmacology Communications, Vol. 5, Iss. 7, 1999-07 ,pp. : 473-478

Pharmaceutical Press

Access to resources Recommend Favorite

Effects of clozapine metabolites and chronic clozapine treatment on rat brain GABA A receptors

By Wong G.   Kuoppamaki M.   Hietala J.   Luddens H.   Syvalahti E.   Korpi E.R.  

European Journal of Pharmacology, Vol. 314, Iss. 3, 1996-10 ,pp. : 319-323

Elsevier

Access to resources Recommend Favorite

Infliximab induced remission in five patients with treatment-refractory Wegener's granulomatosis

By  

Inpharma, Vol. 1, Iss. 1369, 2003-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

What is an Adequate Trial with Clozapine?: Therapeutic Drug Monitoring and Time to Response in Treatment-Refractory Schizophrenia

By Schulte Peter F.J.  

Clinical Pharmacokinetics, Vol. 42, Iss. 7, 2003-01 ,pp. : 607-618

Adis International

Access to resources Recommend Favorite